Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Tralokinumab, Atc D11ah07 For The Time 01.08.2025 31.07.2027 2025-12-13
Germany Open House Medicinal Department Departments Epinephrin, Atc C01ca24 2025-12-13
Germany Open House Pharmaceuticals Budesonide, Atc A07ea06 2025-12-13
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Iron (iii) Derisomalosis, Atc B03ac08 For The Period 01.08.2025-31.07.2027 2025-12-13
Germany Open House Medicinal Department Treaties Tofacitinib, Atc L04af01 2025-12-13
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Nilotinib (except As A Dispatch In Apple Sauce) F. D. Z. 01.8.25 - 31.7.27 (plus Extension Option 1x12 Month) 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Fluorouracil, Atc D11af05 For The Time 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Germany Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Beclometason, Atc R03al09 2025-12-13
Germany Open House Medicinal Department Of Pegintereron Beta-1a, Atc L03ab13 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Safinamide, Atc N04bd03 For The Period 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Whats app